Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab

Satoshi IchikawaDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan; Correspondence[email protected]

Noriko FukuharaDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;

Kei SaitoDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;

Hisayuki YokoyamaDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;

Koichi OnoderaDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;

Yasushi OnishiDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;

Ryo IchinohasamaDepartment of Hematopathology, Tohoku University Hospital, Sendai, Japan

Hideo HarigaeDepartment of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan;

show all

Click to increase image sizeClick to decrease image size

Disclosure statement

The authors declare that they have no conflicts of interest associated with this case report.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab

Information for

Open access

Opportunities

Help and information

Epstein-Barr virus-positive diffuse large B-cell lymphoma after sustained remission of T-cell prolymphocytic leukemia with alemtuzumab

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature